We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test showed a sensitivity of 99.1 percent for correctly identifying positive samples and a specificity of 99.6 percent for accurately detecting negative samples. Read More
Johnson & Johnson (J&J) has reached an advance purchase deal with the European Commission to provide up to 200 million doses of its COVID-19 vaccine candidate. Read More
The European Commission has inked a supply deal with Gilead Sciences for 500,000 courses of the company’s antiviral drug remdesivir to shore up Europe’s depleting stocks of the COVID-19 treatment. Read More
In a move to show it’s a good corporate citizen during the pandemic, Moderna has vowed not to wield its COVID-19 related patents against other coronavirus vaccine manufacturers as the crisis continues. Read More
Even President Trump’s top COVID-19 advisers are starting to scale back their timelines for when a vaccine would be ready for Emergency Use Authorization (EUA) or approval despite the president’s assertions to the contrary. Read More
Regeneron Pharmaceuticals submitted a request for Emergency Use Authorization (EUA) for its COVID-19 antibody treatment Thursday, just one day after Eli Lilly filed for authorization of its own monoclonal antibody. Read More
The automation-friendly test takes less than two hours to deliver results and requires fewer steps, reducing the chances of human error, Omixon said. Read More